Medical marketing leaders weigh in on the temporary respite for TikTok and what it means for pharma clients. After a turbulent weekend, TikTok is back – for the time being.

Scientists reveal new insights into the hidden processes driving human genetic variation with the first complete human DNA ...

Fortune Brands Innovations has leased the majority of the former Horizon Therapeutics headquarters as relocates employees from other cities to the northern suburb.

Researchers at deCODE genetics have developed a groundbreaking DNA map, revealing the intricate process of genetic recombination during reproduction. This map highlights areas of DNA that undergo ...

The stock price of the two most prominent players in the diabetes and obesity care market, Novo Nordisk NVO and Eli Lilly LLY ...

Tezepelumab did not significantly decrease moderate or severe COPD exacerbations compared with placebo, the COURSE trial found.

A small, but positive, randomized double-blind trial of baricitinib for PMR is the first in patients with the condition to ...

Scientists at deCODE genetics/Amgen have constructed a complete map of how human DNA is mixed as it is passed down during ...

Researchers from Mass General Brigham evaluated a drug that represents a new class of anticoagulants known as Factor XI inhibitors for treating patients with atrial fibrillation as part of the ...

In 2024, the FDA approved 19 biosimilars across various therapeutic areas, including the first biosimilars for ustekinumab ...

Arcus Biosciences named former Amgen executive Richard Markus as its chief medical officer. The biopharmaceutical company, which is focused on cancer treatments, said Tuesday that Markus is scheduled ...

Amgen Inc (AMGN) stock saw a modest uptick, ending the day at $272.11 which represents a slight increase of $2.68 or 0.99% from the prior close of $269.43. The stock opened at $276.97 and touched a ...